2026 Compensation Guide

2026 Regulatory Affairs Leader Compensation Guide

Regulatory Affairs leaders own FDA, EMA, and global agency strategy through pivotal trials, BLA/NDA filings, and lifecycle management. Modality (small molecule, biologics, cell and gene therapy, AI/SaMD) drives compensation as much as title.

Request Calibrated Salary Data Regulatory Affairs Recruiters

Written by Darren NelsonReviewed by Recruits Lab Research TeamUpdated 2026

Direct Answer

How do companies hire Regulatory Affairs leaders in 2026?

Most Regulatory Affairs hires happen through specialized search. Director Regulatory Affairs earns $240K-$340K base, Senior Director $300K-$420K, and VP Regulatory Affairs $380K-$580K. All levels carry 20-35 percent target bonus and 0.05-0.40 percent equity at venture-backed biotech. Hires typically take 12-20 weeks given the small qualified candidate pool.

Compensation data is directional and may vary based on geography, company stage, industry, equity, bonus structure, and candidate experience. This guide is an educational resource, not a definitive compensation survey.

Compensation Bands

Base, bonus, and equity by level. All figures are 2026 U.S. directional ranges.

Level	Base Salary	Bonus / OTE	Equity	Notes
Director Regulatory Affairs	$240K-$340K	20-25% ($50K-$85K)	0.08%-0.25%	Owns specific program. Pre-pivotal or post-marketing.
Senior Director Regulatory Affairs	$300K-$420K	22-28% ($65K-$120K)	0.10%-0.30%	Multi-program oversight. Direct agency interaction.
VP Regulatory Affairs	$380K-$520K	30-35% ($110K-$180K)	0.15%-0.40%	Departmental ownership. Pre-launch through commercial.
SVP / Chief Regulatory Officer	$480K-$580K+	35-45% ($170K-$260K+)	0.25%-0.75%	C-suite seat. Often combined with quality and CMC oversight.

Bonus Structure

Regulatory Affairs bonus targets are higher than most life sciences functions, reflecting milestone risk. Bonuses are typically tied to filing dates, agency interactions, and corporate trial milestones (IND, EOP2, BLA submission).

Equity Structure

Venture-backed biotech equity grants are meaningful at Regulatory leadership levels because regulatory wins drive valuation step-ups. Pre-pivotal biotech VP Regulatory grants commonly reach 0.30-0.50 percent for first-in-class indications.

Geographic Comparisons

Market	vs. Baseline	Commentary
Boston / Cambridge	1.00x (baseline)	Highest density of pivotal-stage biotech. Sets the market.
San Francisco Bay Area	1.00x-1.05x	Comparable to Boston. AI/SaMD regulatory experience adds 5-10 percent premium.
San Diego / RTP	0.92x-1.00x	Strong biotech ecosystems. Slightly lower base, comparable equity.
Washington DC Metro	0.95x-1.05x	Premium for former FDA reviewers and proximity-driven roles.
Remote (US)	0.90x-1.00x	Regulatory Affairs is one of the most remote-friendly LS functions.

Hiring Market Commentary

1
Cell and gene therapy and AI/SaMD regulatory experience commands the highest premium in the function. Former FDA CBER reviewers can name their package.
2
Big pharma layoffs in 2024-2025 increased mid-level Regulatory supply but had no impact on Director+ availability.
3
Global Regulatory experience (FDA + EMA + PMDA) is required for the majority of venture-backed VP Regulatory roles given international filing strategies.

Talent Availability

Tight

Director-level Regulatory talent is moderately available. VP and CRO-level regulators with pivotal-stage filing experience in a specific modality are scarce. Specialty regulatory (cell/gene, AI/SaMD, combination products) is very tight.

Market Indicators

●Time-to-hire Director: 10-14 weeks
●Time-to-hire VP Regulatory: 14-20 weeks
●Former FDA reviewer supply: <500 active in industry roles nationally

Recruits Lab Hiring Insights

Patterns we have observed across recent placements in this market.

Pivotal trial timing is the highest-leverage hiring signal. Biotech that hires VP Regulatory 12-18 months before BLA submission outperforms those that hire reactively.
Direct CEO involvement in finalist conversations meaningfully shortens VP Regulatory time-to-hire. This is a board-visible role.
Modality match outperforms title progression. A current Sr. Director with deep cell therapy experience usually beats a VP with general biologics for a CGT startup.

Frequently Asked Questions

How much does a Director of Regulatory Affairs make?+

$240K-$340K base in 2026, plus 20-25 percent target bonus and 0.08-0.25 percent equity at venture-backed biotech. Specialty modality experience can push to the high end.

When should a biotech hire its first VP Regulatory?+

Usually 12-18 months before pivotal trial initiation, and at least 18-24 months before a planned BLA/NDA submission. Hiring earlier shapes agency strategy and reduces filing risk.

Do Regulatory Affairs roles support remote work?+

Yes, in most cases. Regulatory Affairs is one of the more remote-friendly Life Sciences functions, especially at Director+ levels. Some travel for agency meetings and team coordination is expected.